Peter Lamb's most recent trade in Exelixis Inc was a trade of 7,177 Common Stock done at an average price of $16.7 . Disclosure was reported to the exchange on Nov. 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.71 per share. | 15 Nov 2022 | 7,177 | 410,958 (0%) | 0% | 16.7 | 119,928 | Common Stock |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.08 per share. | 15 May 2022 | 6,123 | 396,362 (0%) | 0% | 20.1 | 122,950 | Common Stock |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 59,490 | 402,485 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.59 per share. | 15 Feb 2022 | 17,651 | 342,995 (0%) | 0% | 18.6 | 328,132 | Common Stock |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.59 per share. | 15 Feb 2022 | 2,526 | 360,646 (0%) | 0% | 18.6 | 46,958 | Common Stock |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.10 per share. | 15 Nov 2021 | 53,022 | 349,077 (0%) | 0% | 18.1 | 959,698 | Common Stock |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Sale of securities on an exchange or to another person at price $ 18.09 per share. | 15 Nov 2021 | 47,500 | 411,240 (0%) | 0% | 18.1 | 859,275 | Common Stock |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 47,500 | 47,500 | - | - | Option (right to buy) | |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.21 per share. | 15 Nov 2021 | 47,500 | 458,740 (0%) | 0% | 6.2 | 294,975 | Common Stock |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.10 per share. | 15 Nov 2021 | 6,818 | 404,422 (0%) | 0% | 18.1 | 123,406 | Common Stock |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.10 per share. | 15 Nov 2021 | 2,323 | 402,099 (0%) | 0% | 18.1 | 42,046 | Common Stock |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 28,950 | 418,417 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.63 per share. | 30 Sep 2021 | 7,177 | 411,240 (0%) | 0% | 20.6 | 148,062 | Common Stock |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 55,000 | 0 | - | - | Option (right to buy) | |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.90 per share. | 16 Aug 2021 | 55,000 | 444,467 (0%) | 0% | 1.9 | 104,500 | Common Stock |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Sale of securities on an exchange or to another person at price $ 18.44 per share. | 16 Aug 2021 | 55,000 | 389,467 (0%) | 0% | 18.4 | 1,014,200 | Common Stock |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Sale of securities on an exchange or to another person at price $ 22.18 per share. | 17 Jun 2021 | 60,000 | 389,467 (0%) | 0% | 22.2 | 1,330,800 | Common Stock |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2021 | 60,000 | 115,000 | - | - | Option (right to buy) | |
| Exelixis Inc | Peter Lamb | EVP, Scientific Strategy & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.90 per share. | 17 Jun 2021 | 60,000 | 449,467 (0%) | 0% | 1.9 | 114,000 | Common Stock |